Definium Therapeutics to present at TD Cowen Novel Mechanisms in Neuropsychiatry Summit - DFTX News | RalliesDefinium Therapeutics to present at TD Cowen Novel Mechanisms in Neuropsychiatry Summit
D
DFTX• Company presentation and summit attendance
- Definium Therapeutics schedules a virtual fireside chat on Tuesday, Sept. 1, 2026 at 1:00 p.m. ET.
- Discussion to cover Phase 3 Voyage topline results for DT120 ODT in generalized anxiety disorder.
- Management also slated to present at TD Cowen’s Novel Mechanisms in Neuropsychiatry Summit on Wednesday, Sept. 23, 2026 at 9:30 a.m. ET.
- Company plans to attend the 2026 Leerink Partners Biopharma Summit in Healdsburg, California from Sept. 23-25, 2026.
AIHS
•
